This would improve our understanding of this disorder and could lead to novel strategies—either based on direct modulation of motilin receptor activity or on indirect approaches such as dietary modification or the administration of probiotics—to normalize gut–brain functioning and improve recovery rates in patients with depression. This evidence concerns the gene MLNR and major depressive disorder.